Huge Gainers: Zogenix, Inc. (ZGNX), Tetralogic Pharmaceuticals Corp, WPCS International Incorporated (WPCS) and More

What does the smart money think about Zogenix, Inc. (NASDAQ:ZGNX) and Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI)?

By March 31, a total of 14 of the hedge funds tracked by Insider Monkey were long in Zogenix, a change of 27% from one quarter earlier. Total value of holdings also increased 25.84% from $31.87 million in the fourth quarter to $40.11 million by the end of March. The stock went up 5.11% from January 2 to April 1. Of the funds tracked by Insider Monkey, Kevin Kotler‘s Broadfin Capital had the biggest position in Zogenix, Inc. (NASDAQ:ZGNX), worth close to $14.7 million in 10,737,645 shares, corresponding to 1.1% of its total 13F portfolio. On Broadfin Capital’s heels is Sabby Capital, led by Hal Mintz, holding a $11.5 million position in 8,418,811 shares; the fund has 0.5% of its 13F portfolio invested in the stock. Some other peers with similar optimism include Julian Baker and Felix Baker’s Baker Bros. Advisors, Israel Englander’s Millennium Management and Hal Mintz’s Sabby Capital.

Also at the end of the first quarter, a total of 7 of the hedge funds tracked by Insider Monkey held long positions in Tetralogic, a change of 40% from one quarter earlier. Value of holdings increased from $3.17 million to $3.58 million, up 12.87%, from the end of the fourth quarter of 2014 to the end of the first quarter of 2015. This is a substantial increase as the stock declined 8.71% from January 2 to April 1. According to hedge fund experts at Insider Monkey, Kingdon Capital, managed by Mark Kingdon, holds the biggest position in Tetralogic Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG). Kingdon Capital has a $1.2 million position in 263,827 shares of the company, comprising less than 0.1% of its 13F portfolio. Sitting at the No. 2 spot is Steve Cohen of Point72 Asset Management, with 125,559 shares worth about$550,000; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Some other hedge funds with similar optimism contain Stuart Weisbrod’s Iguana Healthcare Management, Anand Parekh’s Alyeska Investment Group and Efrem Kamen’s Pura Vida Investments.

Disclosure: None